Data is not available at this time.
Microsaic Systems plc operates in the specialized niche of miniaturized mass spectrometry (MS) instruments, catering to industries such as pharmaceuticals, food safety, environmental monitoring, and academia. The company’s core revenue model revolves around the development and commercialization of its MiD platform solutions, including the 4500 MiD and MiDas Automated Sampling interface, alongside consumables and support services. By focusing on portable, real-time MS detection, Microsaic addresses the growing demand for in-field analytical tools, differentiating itself from traditional, bulkier laboratory equipment providers. The company leverages OEM partnerships and distributors to expand its global footprint, particularly in the UK, Japan, and the US. Despite its innovative technology, Microsaic operates in a competitive landscape dominated by larger players, requiring strategic investments in R&D and market penetration to sustain growth. Its niche positioning offers potential for high-margin applications but depends on broader adoption of miniaturized MS solutions in industrial and regulatory settings.
Microsaic reported revenue of £492,000 for FY 2023, reflecting its early-stage commercialization efforts. The company’s net loss of £2.6 million underscores ongoing challenges in scaling profitability, with negative operating cash flow of £1.1 million highlighting significant cash burn. Capital expenditures were minimal at £2,000, suggesting limited near-term capacity expansion. The revenue base remains small, indicating reliance on strategic partnerships or product adoption breakthroughs to achieve sustainable margins.
The diluted EPS of -26p and negative net income demonstrate Microsaic’s current lack of earnings power, typical of a development-stage technology firm. With minimal debt (£21,000) and modest cash reserves (£173,000), the company’s capital efficiency hinges on its ability to monetize its MS platforms. Operating cash flow constraints suggest a need for external funding or accelerated revenue growth to bridge the gap to profitability.
Microsaic’s balance sheet reflects a fragile financial position, with cash and equivalents of £173,000 against negligible debt. The limited liquidity raises concerns about near-term solvency unless supplemented by equity raises or grants. The absence of significant tangible assets underscores the company’s asset-light, IP-driven model, which may appeal to investors if technology validation accelerates.
Microsaic’s growth trajectory is nascent, with revenue yet to reflect broad market adoption. The company does not pay dividends, reinvesting limited resources into R&D and commercialization. Future growth depends on expanding its OEM network and proving the cost-effectiveness of its miniaturized MS solutions in target industries.
With a market cap of approximately £1.5 million, Microsaic trades as a speculative play on miniaturized MS technology. The low beta (0.27) suggests limited correlation with broader markets, but investor sentiment likely hinges on near-term commercialization milestones or partnerships. The valuation reflects high uncertainty around scalability and competitive positioning.
Microsaic’s key advantage lies in its proprietary miniaturized MS technology, which addresses unmet needs for portable, real-time analysis. However, execution risks—including funding constraints and competition—cloud the outlook. Success depends on securing strategic alliances, regulatory approvals, and demonstrating cost advantages over conventional MS systems in niche applications.
Company filings, London Stock Exchange disclosures
show cash flow forecast
| Fiscal year | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |